Ethnicity, recurrence score distribution, and clinical outcomes in ER + HER2-negative breast cancer patients in Israel: A registry analysis
- PMID: 32419268
- DOI: 10.1111/tbj.13870
Ethnicity, recurrence score distribution, and clinical outcomes in ER + HER2-negative breast cancer patients in Israel: A registry analysis
References
REFERENCES
-
- Albain K, Gray RJ, Sparano JA, et al. Race, ethnicity and clinical outcomes in hormone receptor-positive, HER2-negative, node-negative breast cancer: results from the TAILORx trial. Cancer Res. 2019;79(4 Suppl):Abstract nr GS4-07.
-
- Stemmer SM, Steiner M, Rizel S, et al. Ten-year clinical outcomes in N0 ER+ breast cancer patients with Recurrence Score-guided therapy. NPJ Breast Cancer. 2019;5:41.
-
- Guth AA, Chun Kim J, Schwartz S, et al. The relationship of race, Oncotype DX, and Ki67 in a population highly screened for breast cancer. Breast J. 2017;23:177-181.
-
- Holowatyj AN, Cote ML, Ruterbusch JJ, et al. Racial differences in 21-gene Recurrence Scores among patients with hormone receptor-positive, node-negative breast cancer. J Clin Oncol. 2018;36:652-658.
-
- Lewin R, Sulkes A, Shochat T, et al. Oncotype-DX recurrence score distribution in breast cancer patients with BRCA1/2 mutations. Breast Cancer Res Treat. 2016;157:511-516.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
